Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Alpha L-Iduronidase Market Growth 2021-2026

  • LP 4691975
  • 108 Pages
  • December 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
According to this latest study, the 2021 growth of Alpha L-Iduronidase will have significant change from previous year. By the most conservative estimates of global Alpha L-Iduronidase market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Alpha L-Iduronidase market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Alpha L-Iduronidase market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

IDUA

EC 3.2.1.76

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Oncology

Dermatology

Immunology

Musculoskeletal Disorders

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

ArmaGen Inc

BioStrategies LC

Denali Therapeutics Inc

EdiGene Inc

Gain Therapeutics Inc

Immusoft Corp

JCR Pharmaceuticals Co Ltd

Orchard Therapeutics Plc

Ossianix Inc

Rain Bio Inc

RegenxBio Inc

Tega Therapeutics Inc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Alpha L-Iduronidase Consumption 2016-2026

2.1.2 Alpha L-Iduronidase Consumption CAGR by Region

2.2 Alpha L-Iduronidase Segment by Type

2.2.1 IDUA

2.2.2 EC 3.2.1.76

2.3 Alpha L-Iduronidase Sales by Type

2.3.1 Global Alpha L-Iduronidase Sales Market Share by Type (2016-2021)

2.3.2 Global Alpha L-Iduronidase Revenue and Market Share by Type (2016-2021)

2.3.3 Global Alpha L-Iduronidase Sale Price by Type (2016-2021)

2.4 Alpha L-Iduronidase Segment by Application

2.4.1 Oncology

2.4.2 Dermatology

2.4.3 Immunology

2.4.4 Musculoskeletal Disorders

2.5 Alpha L-Iduronidase Sales by Application

2.5.1 Global Alpha L-Iduronidase Sale Market Share by Application (2016-2021)

2.5.2 Global Alpha L-Iduronidase Revenue and Market Share by Application (2016-2021)

2.5.3 Global Alpha L-Iduronidase Sale Price by Application (2016-2021)

3 Global Alpha L-Iduronidase by Company

3.1 Global Alpha L-Iduronidase Sales Market Share by Company

3.1.1 Global Alpha L-Iduronidase Sales by Company (2019-2021)

3.1.2 Global Alpha L-Iduronidase Sales Market Share by Company (2019-2021)

3.2 Global Alpha L-Iduronidase Revenue Market Share by Company

3.2.1 Global Alpha L-Iduronidase Revenue by Company (2019-2021)

3.2.2 Global Alpha L-Iduronidase Revenue Market Share by Company (2019-2021)

3.3 Global Alpha L-Iduronidase Sale Price by Company

3.4 Global Manufacturers Alpha L-Iduronidase Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Alpha L-Iduronidase Product Location Distribution

3.4.2 Players Alpha L-Iduronidase Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Alpha L-Iduronidase by Region

4.1 Global Alpha L-Iduronidase by Region

4.1.1 Global Alpha L-Iduronidase Sales by Region

4.1.2 Global Alpha L-Iduronidase Revenue by Region

4.2 Americas Alpha L-Iduronidase Sales Growth

4.3 APAC Alpha L-Iduronidase Sales Growth

4.4 Europe Alpha L-Iduronidase Sales Growth

4.5 Middle East & Africa Alpha L-Iduronidase Sales Growth

5 Americas

5.1 Americas Alpha L-Iduronidase Sales by Country

5.1.1 Americas Alpha L-Iduronidase Sales by Country (2016-2021)

5.1.2 Americas Alpha L-Iduronidase Revenue by Country (2016-2021)

5.2 Americas Alpha L-Iduronidase Sales by Type

5.3 Americas Alpha L-Iduronidase Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Alpha L-Iduronidase Sales by Region

6.1.1 APAC Alpha L-Iduronidase Sales by Region (2016-2021)

6.1.2 APAC Alpha L-Iduronidase Revenue by Region (2016-2021)

6.2 APAC Alpha L-Iduronidase Sales by Type

6.3 APAC Alpha L-Iduronidase Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Alpha L-Iduronidase by Country

7.1.1 Europe Alpha L-Iduronidase Sales by Country (2016-2021)

7.1.2 Europe Alpha L-Iduronidase Revenue by Country (2016-2021)

7.2 Europe Alpha L-Iduronidase Sales by Type

7.3 Europe Alpha L-Iduronidase Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Alpha L-Iduronidase by Country

8.1.1 Middle East & Africa Alpha L-Iduronidase Sales by Country (2016-2021)

8.1.2 Middle East & Africa Alpha L-Iduronidase Revenue by Country (2016-2021)

8.2 Middle East & Africa Alpha L-Iduronidase Sales by Type

8.3 Middle East & Africa Alpha L-Iduronidase Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Alpha L-Iduronidase Distributors

10.3 Alpha L-Iduronidase Customer

11 Global Alpha L-Iduronidase Market Forecast

11.1 Global Alpha L-Iduronidase Forecast by Region

11.1.1 Global Alpha L-Iduronidase Forecast by Regions (2021-2026)

11.2.2 Global Alpha L-Iduronidase Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Alpha L-Iduronidase Forecast by Type

11.7 Global Alpha L-Iduronidase Forecast by Application

12 Key Players Analysis

12.1 ArmaGen Inc

12.1.1 ArmaGen Inc Company Information

12.1.2 ArmaGen Inc Alpha L-Iduronidase Product Offered

12.1.3 ArmaGen Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 ArmaGen Inc Main Business Overview

12.1.5 ArmaGen Inc Latest Developments

12.2 BioStrategies LC

12.2.1 BioStrategies LC Company Information

12.2.2 BioStrategies LC Alpha L-Iduronidase Product Offered

12.2.3 BioStrategies LC Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 BioStrategies LC Main Business Overview

12.2.5 BioStrategies LC Latest Developments

12.3 Denali Therapeutics Inc

12.3.1 Denali Therapeutics Inc Company Information

12.3.2 Denali Therapeutics Inc Alpha L-Iduronidase Product Offered

12.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Denali Therapeutics Inc Main Business Overview

12.3.5 Denali Therapeutics Inc Latest Developments

12.4 EdiGene Inc

12.4.1 EdiGene Inc Company Information

12.4.2 EdiGene Inc Alpha L-Iduronidase Product Offered

12.4.3 EdiGene Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 EdiGene Inc Main Business Overview

12.4.5 EdiGene Inc Latest Developments

12.5 Gain Therapeutics Inc

12.5.1 Gain Therapeutics Inc Company Information

12.5.2 Gain Therapeutics Inc Alpha L-Iduronidase Product Offered

12.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Gain Therapeutics Inc Main Business Overview

12.5.5 Gain Therapeutics Inc Latest Developments

12.6 Immusoft Corp

12.6.1 Immusoft Corp Company Information

12.6.2 Immusoft Corp Alpha L-Iduronidase Product Offered

12.6.3 Immusoft Corp Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Immusoft Corp Main Business Overview

12.6.5 Immusoft Corp Latest Developments

12.7 JCR Pharmaceuticals Co Ltd

12.7.1 JCR Pharmaceuticals Co Ltd Company Information

12.7.2 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Offered

12.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 JCR Pharmaceuticals Co Ltd Main Business Overview

12.7.5 JCR Pharmaceuticals Co Ltd Latest Developments

12.8 Orchard Therapeutics Plc

12.8.1 Orchard Therapeutics Plc Company Information

12.8.2 Orchard Therapeutics Plc Alpha L-Iduronidase Product Offered

12.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Orchard Therapeutics Plc Main Business Overview

12.8.5 Orchard Therapeutics Plc Latest Developments

12.9 Ossianix Inc

12.9.1 Ossianix Inc Company Information

12.9.2 Ossianix Inc Alpha L-Iduronidase Product Offered

12.9.3 Ossianix Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Ossianix Inc Main Business Overview

12.9.5 Ossianix Inc Latest Developments

12.10 Rain Bio Inc

12.10.1 Rain Bio Inc Company Information

12.10.2 Rain Bio Inc Alpha L-Iduronidase Product Offered

12.10.3 Rain Bio Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Rain Bio Inc Main Business Overview

12.10.5 Rain Bio Inc Latest Developments

12.11 RegenxBio Inc

12.11.1 RegenxBio Inc Company Information

12.11.2 RegenxBio Inc Alpha L-Iduronidase Product Offered

12.11.3 RegenxBio Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 RegenxBio Inc Main Business Overview

12.11.5 RegenxBio Inc Latest Developments

12.12 Tega Therapeutics Inc

12.12.1 Tega Therapeutics Inc Company Information

12.12.2 Tega Therapeutics Inc Alpha L-Iduronidase Product Offered

12.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Tega Therapeutics Inc Main Business Overview

12.12.5 Tega Therapeutics Inc Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Alpha L-Iduronidase Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of IDUA

Table 3. Major Players of EC 3.2.1.76

Table 4. Global Alpha L-Iduronidase Sales by Type (2016-2021) & (K Units)

Table 5. Global Alpha L-Iduronidase Sales Market Share by Type (2016-2021)

Table 6. Global Alpha L-Iduronidase Revenue by Type (2016-2021) & ($ million)

Table 7. Global Alpha L-Iduronidase Revenue Market Share by Type (2016-2021)

Table 8. Global Alpha L-Iduronidase Sale Price by Type (2016-2021)

Table 9. Global Alpha L-Iduronidase Sales by Application (2016-2021) & (K Units)

Table 10. Global Alpha L-Iduronidase Sales Market Share by Application (2016-2021)

Table 11. Global Alpha L-Iduronidase Value by Application (2016-2021)

Table 12. Global Alpha L-Iduronidase Revenue Market Share by Application (2016-2021)

Table 13. Global Alpha L-Iduronidase Sale Price by Application (2016-2021)

Table 14. Global Alpha L-Iduronidase Sales by Company (2019-2021) & (K Units)

Table 15. Global Alpha L-Iduronidase Sales Market Share by Company (2019-2021)

Table 16. Global Alpha L-Iduronidase Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Alpha L-Iduronidase Revenue Market Share by Company (2019-2021)

Table 18. Global Alpha L-Iduronidase Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Alpha L-Iduronidase Producing Area Distribution and Sales Area

Table 20. Players Alpha L-Iduronidase Products Offered

Table 21. Alpha L-Iduronidase Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Alpha L-Iduronidase Sales by Region (2016-2021) (K Units)

Table 25. Global Alpha L-Iduronidase Sales Market Share by Region (2016-2021)

Table 26. Global Alpha L-Iduronidase Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Alpha L-Iduronidase Revenue Market Share by Region (2016-2021)

Table 28. Americas Alpha L-Iduronidase Sales by Country (2016-2021) & (K Units)

Table 29. Americas Alpha L-Iduronidase Sales Market Share by Country (2016-2021)

Table 30. Americas Alpha L-Iduronidase Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Alpha L-Iduronidase Revenue Market Share by Country (2016-2021)

Table 32. Americas Alpha L-Iduronidase Sales by Type (2016-2021) & (K Units)

Table 33. Americas Alpha L-Iduronidase Sales Market Share by Type (2016-2021)

Table 34. Americas Alpha L-Iduronidase Sales by Application (2016-2021) & (K Units)

Table 35. Americas Alpha L-Iduronidase Sales Market Share by Application (2016-2021)

Table 36. APAC Alpha L-Iduronidase Sales by Region (2016-2021) & (K Units)

Table 37. APAC Alpha L-Iduronidase Sales Market Share by Region (2016-2021)

Table 38. APAC Alpha L-Iduronidase Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Alpha L-Iduronidase Revenue Market Share by Region (2016-2021)

Table 40. APAC Alpha L-Iduronidase Sales by Type (2016-2021) & (K Units)

Table 41. APAC Alpha L-Iduronidase Sales Market Share by Type (2016-2021)

Table 42. APAC Alpha L-Iduronidase Sales by Application (2016-2021) & (K Units)

Table 43. APAC Alpha L-Iduronidase Sales Market Share by Application (2016-2021)

Table 44. Europe Alpha L-Iduronidase Sales by Country (2016-2021) & (K Units)

Table 45. Europe Alpha L-Iduronidase Sales Market Share by Country (2016-2021)

Table 46. Europe Alpha L-Iduronidase Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Alpha L-Iduronidase Revenue Market Share by Country (2016-2021)

Table 48. Europe Alpha L-Iduronidase Sales by Type (2016-2021) & (K Units)

Table 49. Europe Alpha L-Iduronidase Sales Market Share by Type (2016-2021)

Table 50. Europe Alpha L-Iduronidase Sales by Application (2016-2021) & (K Units)

Table 51. Europe Alpha L-Iduronidase Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Alpha L-Iduronidase Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Alpha L-Iduronidase Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Alpha L-Iduronidase Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Alpha L-Iduronidase Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Alpha L-Iduronidase Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Alpha L-Iduronidase

Table 61. Key Application and Potential Industries of Alpha L-Iduronidase

Table 62. Key Challenges of Alpha L-Iduronidase

Table 63. Key Trends of Alpha L-Iduronidase

Table 64. Alpha L-Iduronidase Distributors List

Table 65. Alpha L-Iduronidase Customer List

Table 66. Global Alpha L-Iduronidase Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Alpha L-Iduronidase Consumption Market Forecast by Region

Table 68. Global Alpha L-Iduronidase Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Alpha L-Iduronidase Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Alpha L-Iduronidase Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Alpha L-Iduronidase Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Alpha L-Iduronidase Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Alpha L-Iduronidase Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Alpha L-Iduronidase Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Alpha L-Iduronidase Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Alpha L-Iduronidase Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Alpha L-Iduronidase Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Alpha L-Iduronidase Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Alpha L-Iduronidase Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Alpha L-Iduronidase Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Alpha L-Iduronidase Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Alpha L-Iduronidase Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Alpha L-Iduronidase Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Alpha L-Iduronidase Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Alpha L-Iduronidase Revenue Market Share Forecast by Application (2021-2026)

Table 86. ArmaGen Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 87. ArmaGen Inc Alpha L-Iduronidase Product Offered

Table 88. ArmaGen Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. ArmaGen Inc Main Business

Table 90. ArmaGen Inc Latest Developments

Table 91. BioStrategies LC Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 92. BioStrategies LC Alpha L-Iduronidase Product Offered

Table 93. BioStrategies LC Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. BioStrategies LC Main Business

Table 95. BioStrategies LC Latest Developments

Table 96. Denali Therapeutics Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 97. Denali Therapeutics Inc Alpha L-Iduronidase Product Offered

Table 98. Denali Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. Denali Therapeutics Inc Main Business

Table 100. Denali Therapeutics Inc Latest Developments

Table 101. EdiGene Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 102. EdiGene Inc Alpha L-Iduronidase Product Offered

Table 103. EdiGene Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. EdiGene Inc Main Business

Table 105. EdiGene Inc Latest Developments

Table 106. Gain Therapeutics Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 107. Gain Therapeutics Inc Alpha L-Iduronidase Product Offered

Table 108. Gain Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 109. Gain Therapeutics Inc Main Business

Table 110. Gain Therapeutics Inc Latest Developments

Table 111. Immusoft Corp Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 112. Immusoft Corp Alpha L-Iduronidase Product Offered

Table 113. Immusoft Corp Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 114. Immusoft Corp Main Business

Table 115. Immusoft Corp Latest Developments

Table 116. JCR Pharmaceuticals Co Ltd Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 117. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Offered

Table 118. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 119. JCR Pharmaceuticals Co Ltd Main Business

Table 120. JCR Pharmaceuticals Co Ltd Latest Developments

Table 121. Orchard Therapeutics Plc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 122. Orchard Therapeutics Plc Alpha L-Iduronidase Product Offered

Table 123. Orchard Therapeutics Plc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 124. Orchard Therapeutics Plc Main Business

Table 125. Orchard Therapeutics Plc Latest Developments

Table 126. Ossianix Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 127. Ossianix Inc Alpha L-Iduronidase Product Offered

Table 128. Ossianix Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 129. Ossianix Inc Main Business

Table 130. Ossianix Inc Latest Developments

Table 131. Rain Bio Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 132. Rain Bio Inc Alpha L-Iduronidase Product Offered

Table 133. Rain Bio Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 134. Rain Bio Inc Main Business

Table 135. Rain Bio Inc Latest Developments

Table 136. RegenxBio Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 137. RegenxBio Inc Alpha L-Iduronidase Product Offered

Table 138. RegenxBio Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 139. RegenxBio Inc Main Business

Table 140. RegenxBio Inc Latest Developments

Table 141. Tega Therapeutics Inc Basic Information, Alpha L-Iduronidase Manufacturing Base, Sales Area and Its Competitors

Table 142. Tega Therapeutics Inc Alpha L-Iduronidase Product Offered

Table 143. Tega Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 144. Tega Therapeutics Inc Main Business

Table 145. Tega Therapeutics Inc Latest Developments

List of Figures

Figure 1. Picture of Alpha L-Iduronidase

Figure 2. Alpha L-Iduronidase Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Alpha L-Iduronidase Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Alpha L-Iduronidase Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Alpha L-Iduronidase Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of IDUA

Figure 10. Product Picture of EC 3.2.1.76

Figure 11. Global Alpha L-Iduronidase Sales Market Share by Type in 2020

Figure 12. Global Alpha L-Iduronidase Revenue Market Share by Type (2016-2021)

Figure 13. Alpha L-Iduronidase Consumed in Oncology

Figure 14. Global Alpha L-Iduronidase Market: Oncology (2016-2021) & (K Units)

Figure 15. Alpha L-Iduronidase Consumed in Dermatology

Figure 16. Global Alpha L-Iduronidase Market: Dermatology (2016-2021) & (K Units)

Figure 17. Alpha L-Iduronidase Consumed in Immunology

Figure 18. Global Alpha L-Iduronidase Market: Immunology (2016-2021) & (K Units)

Figure 19. Alpha L-Iduronidase Consumed in Musculoskeletal Disorders

Figure 20. Global Alpha L-Iduronidase Market: Musculoskeletal Disorders (2016-2021) & (K Units)

Figure 21. Global Alpha L-Iduronidase Sales Market Share by Application (2016-2021)

Figure 22. Global Alpha L-Iduronidase Revenue Market Share by Application in 2020

Figure 23. Alpha L-Iduronidase Revenue Market by Company in 2020 ($ Million)

Figure 24. Global Alpha L-Iduronidase Revenue Market Share by Company in 2020

Figure 25. Global Alpha L-Iduronidase Sales Market Share by Regions (2016-2021)

Figure 26. Global Alpha L-Iduronidase Revenue Market Share by Region in 2020

Figure 27. Americas Alpha L-Iduronidase Sales 2016-2021 (K Units)

Figure 28. Americas Alpha L-Iduronidase Revenue 2016-2021 ($ Millions)

Figure 29. APAC Alpha L-Iduronidase Sales 2016-2021 (K Units)

Figure 30. APAC Alpha L-Iduronidase Revenue 2016-2021 ($ Millions)

Figure 31. Europe Alpha L-Iduronidase Sales 2016-2021 (K Units)

Figure 32. Europe Alpha L-Iduronidase Revenue 2016-2021 ($ Millions)

Figure 33. Middle East & Africa Alpha L-Iduronidase Sales 2016-2021 (K Units)

Figure 34. Middle East & Africa Alpha L-Iduronidase Revenue 2016-2021 ($ Millions)

Figure 35. Americas Alpha L-Iduronidase Sales Market Share by Country in 2020

Figure 36. Americas Alpha L-Iduronidase Revenue Market Share by Country in 2020

Figure 37. Americas Alpha L-Iduronidase Sales Market Share by Type in 2020

Figure 38. Americas Alpha L-Iduronidase Sales Market Share by Application in 2020

Figure 39. United States Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 40. Canada Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 41. Mexico Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 42. Brazil Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 43. APAC Alpha L-Iduronidase Sales Market Share by Region in 2020

Figure 44. APAC Alpha L-Iduronidase Revenue Market Share by Regions in 2020

Figure 45. APAC Alpha L-Iduronidase Sales Market Share by Type in 2020

Figure 46. APAC Alpha L-Iduronidase Sales Market Share by Application in 2020

Figure 47. China Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 48. Japan Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 49. Korea Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 50. Southeast Asia Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 51. India Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 52. Australia Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 53. Europe Alpha L-Iduronidase Sales Market Share by Country in 2020

Figure 54. Europe Alpha L-Iduronidase Revenue Market Share by Country in 2020

Figure 55. Europe Alpha L-Iduronidase Sales Market Share by Type in 2020

Figure 56. Europe Alpha L-Iduronidase Sales Market Share by Application in 2020

Figure 57. Germany Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 58. France Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 59. UK Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 60. Italy Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 61. Russia Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 62. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Country in 2020

Figure 63. Middle East & Africa Alpha L-Iduronidase Revenue Market Share by Country in 2020

Figure 64. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Type in 2020

Figure 65. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Application in 2020

Figure 66. Egypt Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 67. South Africa Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 68. Israel Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 69. Turkey Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 70. GCC Country Alpha L-Iduronidase Revenue Growth 2016-2021 ($ Millions)

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390